Company / Financials
RxSight, Inc. Financials
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$89.1M
FY2025 · +81.8% YoY
Net Income
-$48.6M
FY2025 · +27.2% YoY
Profit Margin
-54.6%
FY2025 · net income / revenue
ROE
-17.6%
FY2025 · return on equity
Total Assets
$311.8M
FY2025
Total Debt
-
FY2025
Equity
$275.7M
FY2025
ROA
-15.6%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 3.59 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$89.1M+81.8% YoYNet Income HistoryProfit after all expenses and taxes-$48.6M+27.2% YoYGross Profit HistoryRevenue minus cost of goods sold$53.8M+152.1% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$35.3M+27.6% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$50.1M+20.9% YoYSG&A Expense HistorySelling, general, and administrative expenses$74.8M+27.5% YoYR&D Expense HistoryResearch and development spending$29.1M+11.8% YoYInterest Expense HistoryCost of borrowing and debt obligations$3.3M-33.1% YoYIncome Tax HistoryTotal income tax expense$20.0K+122.2% YoYEPS (Basic) HistoryBasic earnings per share-$1.41+41.5% YoY